These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW. J Am Coll Cardiol; 2008 Mar 25; 51(12):1188-95. PubMed ID: 18355657 [Abstract] [Full Text] [Related]
4. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels. Tello-Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, Vicente V, Lip GY. J Intern Med; 2007 Dec 25; 262(6):651-8. PubMed ID: 17986200 [Abstract] [Full Text] [Related]
6. Transition from CK-MB to troponin did not improve the 1 year mortality of non-ST elevation acute coronary syndromes. Novack V, Jotkowitz AB, Cutlip D, Amit G, Liebermann N, Porath A. Postgrad Med J; 2008 Jan 25; 84(987):50-5. PubMed ID: 18230752 [Abstract] [Full Text] [Related]
10. In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers. Giansante C, Fiotti N, Di Chiara A, Altamura N, Wasserman S, Fioretti P, Guarnieri G. J Cardiovasc Med (Hagerstown); 2007 Aug 15; 8(8):602-7. PubMed ID: 17667031 [Abstract] [Full Text] [Related]
12. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Sinnaeve PR, Steg PG, Fox KA, Van de Werf F, Montalescot G, Granger CB, Knobel E, Anderson FA, Dabbous OH, Avezum A, GRACE Investigators. Arch Intern Med; 2009 Feb 23; 169(4):402-9. PubMed ID: 19237725 [Abstract] [Full Text] [Related]
14. Relationship between risk stratification by cardiac troponin level and adherence to guidelines for non-ST-segment elevation acute coronary syndromes. Roe MT, Peterson ED, Li Y, Pollack CV, Christenson RH, Peacock WF, Fesmire FM, Newby LK, Jesse RL, Hoekstra JW, Gibler WB, Ohman EM. Arch Intern Med; 2005 Sep 12; 165(16):1870-6. PubMed ID: 16157831 [Abstract] [Full Text] [Related]
15. Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes. Yan AT, Yan RT, Tan M, Fung A, Cohen EA, Fitchett DH, Langer A, Goodman SG, Canadian Acute Coronary Syndromes 1 and 2 Registry Investigators. Arch Intern Med; 2007 May 28; 167(10):1009-16. PubMed ID: 17533203 [Abstract] [Full Text] [Related]
17. Prevalence, characteristics and outcomes of people aged 65 years and over with an incidental rise in cardiac troponin I. An observational prospective cohort study. Myint PK, Al-Jawad M, Chacko SM, Chu GS, Vowler SL, May HM. Cardiology; 2008 May 28; 110(1):62-7. PubMed ID: 17934271 [Abstract] [Full Text] [Related]
19. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study. Hara H, Nakamura M, Yokouchi I, Kimura K, Nemoto N, Ito S, Ono T, Itaya H, Shiba M, Wada M, Iijima R, Yamamoto M, Yamamoto M, Hara H, Takagi T, Asahara T, Mitsuo K, Kobayashi N, Sugi K. Ther Adv Cardiovasc Dis; 2009 Oct 28; 3(5):357-65. PubMed ID: 19638365 [Abstract] [Full Text] [Related]